The Effect of Mandala on Nausea, Vomiting, Pain and Anxiety in Chemotherapy Patients
Launched by CUKUROVA UNIVERSITY · Jul 12, 2024
Trial Information
Current as of June 03, 2025
Completed
Keywords
ClinConnect Summary
This clinical trial is studying the effects of mandala art therapy, which involves coloring, on children who are receiving chemotherapy. The goal is to see if this creative activity can help reduce nausea, vomiting, pain, and anxiety during their treatment. By engaging in coloring, the children might be able to distract themselves from the discomfort and stress often associated with cancer treatment.
To be eligible for this study, children need to be visiting the pediatric chemotherapy clinic for outpatient treatment and must be receiving chemotherapy regularly. Both the child and their mother should be able to communicate in Turkish, and the child should know basic colors. However, children with certain mental health issues or disabilities that limit their ability to see or use their hands will not be able to participate. If your child joins the trial, they will have the opportunity to engage in fun coloring activities while receiving treatment, which could help them feel better during this challenging time.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Being at the pediatric chemotherapy clinic to receive outpatient chemotherapy
- • Receiving daily chemotherapy
- • Those who agreed to participate in the research
- • Mother and child must know Turkish
- • The child knows colors
- Exclusion Criteria:
- • Having a mental health problem (preventing the use of Mandala therapy coloring technique)
- • Having a disability that prevents you from seeing or using your hand (a condition that prevents you from using the Mandala therapy coloring technique)
About Cukurova University
Cukurova University, a prominent institution located in Adana, Turkey, is dedicated to advancing medical research and improving healthcare outcomes through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university fosters a dynamic research environment that promotes the development of new therapies and treatment modalities. Its commitment to ethical standards and patient safety ensures that all clinical trials are conducted with the highest level of scientific rigor. Cukurova University aims to contribute significantly to the global medical community by facilitating groundbreaking studies that address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Adana, Balçalı, Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported